User profiles for Tabitha Mahungu

Tabitha W Mahungu

Department of Virology, Royal Free London NHS Foundation Trust
Verified email at nhs.net
Cited by 6814

[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK

…, J Joyce, L Lamb, A Lyons, T Mahungu… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …

[HTML][HTML] Late Ebola virus relapse causing meningoencephalitis: a case report

…, R Lester, RSN Liu, A MacConnachie, T Mahungu… - The Lancet, 2016 - thelancet.com
Background There are thousands of survivors of the 2014 Ebola outbreak in west Africa.
Ebola virus can persist in survivors for months in immune-privileged sites; however, viral …

[HTML][HTML] ChAd63-MVA–vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

…, NA Anagnostou, KJ Ewer, T Havelock, T Mahungu… - Molecular Therapy, 2012 - cell.com
The induction of cellular immunity, in conjunction with antibodies, may be essential for
vaccines to protect against blood-stage infection with the human malaria parasite Plasmodium …

[HTML][HTML] Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine …

…, GA O'Hara, FD Halstead, KJ Ewer, T Mahungu… - PloS one, 2012 - journals.plos.org
Background Traditionally, vaccine development against the blood-stage of Plasmodium
falciparum infection has focused on recombinant protein-adjuvant formulations in order to …

Decline in hepatitis C virus (HCV) incidence in men who have sex with men living with human immunodeficiency virus: progress to HCV microelimination in the United …

…, L Jain, LJ Waters, T Mahungu… - Clinical Infectious …, 2021 - academic.oup.com
Modeling of the London hepatitis C virus (HCV) epidemic in men who have sex with men (MSM)
and are living with human immunodeficiency virus (HIV) suggested that early access to …

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics

…, M Lanzman, Z Stone, T Mahungu… - Journal of …, 2021 - academic.oup.com
Background COVID-19 is infrequently complicated by bacterial co-infection, but antibiotic
prescriptions are common. We used community-acquired pneumonia (CAP) as a benchmark to …

[HTML][HTML] HIV as a chronic disease

TW Mahungu, AJ Rodger, MA Johnson - Clinical Medicine, 2009 - ncbi.nlm.nih.gov
The 25th anniversary of the first reports of a catastrophic illness later classified as AIDS and
the 10th anniversary of highly active antiretroviral therapy (HAART) both occurred in 2006. …

[HTML][HTML] The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread

…, P Holenya, C Atkinson, G Tang, T Mahungu… - Nature …, 2023 - nature.com
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A
recombinant form of a protein essential for CMV entry, glycoprotein B (gB), demonstrated partial …

SARS-CoV-2 lineage B. 1.1. 7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study

…, A Holmes, J Hughes, T Mahungu… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Background SARS-CoV-2 lineage B.1.1.7 has been associated with an increased rate of
transmission and disease severity among subjects testing positive in the community. Its impact …

Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study

…, M Panca, A Holmes, N Machin, GY Shin, T Mahungu… - Elife, 2022 - elifesciences.org
Background: Viral sequencing of SARS-CoV-2 has been used for outbreak investigation,
but there is limited evidence supporting routine use for infection prevention and control (IPC) …